MedPath

Environmental Factors and Embryonic Development Project

Conditions
Low Birth Weight
Gestational Hypertension
Spontaneous Abortion
Birth Defects
Preterm Birth
Gestational Diabetes
Stillbirth
Pregnancy With Medical Condition (Non-Specific)
Fetal Death
Interventions
Other: No intervention
Registration Number
NCT04182503
Lead Sponsor
Jinling Hospital, China
Brief Summary

The Environmental Factors and Embryonic Development Project was set up to investigate environmental exposures and behavioral factors responsible for embryonic dysplasia and gestational complications in pregnant women.

Detailed Description

The Environmental Factors and Embryonic Development Project is about to recruit pregnant women from 16 cities, including Beijing, Guangzhou, Jinan, Nanjing, Hangzhou, Wuhan, Zunyi, Xiangyang, Nantong, Suizhou, Huangshi, Changzhou, Suqian, Shiyan, Xiaogan, and Huanggang. The project plans to recruit 6000-12000 participants in each city. Biological samples, questionnaires and data for embryonic dysplasia and gestational complications of pregnant women will be collected. The study includes four stages. In the first stage, the investigators will identify external environmental factors and behavioral factors that are associated with embryonic dysplasia and gestational complications in pregnant women based on external exposure monitoring strategies. In the second and third stages, the investigators will conduct several nested case-control studies based on our prospective cohort. Internal exposure monitoring will be applied to identify environmental endocrine disruptors which are associated with embryonic dysplasia and gestational complications in pregnant women in the second stage. In the third stage, the investigators will conduct genome-wide association study (GWAS) to screen susceptible genes or polymorphisms that are associated with embryonic dysplasia and gestational complications in pregnant women, identify any gene-environmental interactions with reference to the findings of the 1st and 2nd stages, and finally establish a comprehensive disease risk prediction model. In the fourth stage, the investigators will build animal models in order to identify the mechanisms how high-risk environmental exposures or behavioral factors as identified in the above stages may lead to embryonic dysplasia and gestational complications in pregnant women. The research team of the 16 cities are from Peking University (Beijing), Sun Yat-sen University (Guangzhou), Shandong University (Jinan), Chinese People's Liberation Army Eastern Theater General Hospital (Nanjing, Nantong, Changzhou, and Suqian), Zhejiang University (Hangzhou), Huazhong University of Science and Technology (Wuhan, Xiangyang, Suizhou, Huangshi, Shiyan, Xiaogan, and Huanggang), Zunyi Medical University (Zunyi), respectively. The core members of each research team are composed of experts from different disciplines in the field of public health.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100000
Inclusion Criteria
  1. pregnancy within 13 weeks;
  2. age between 20-45 years;
  3. natural conception;
  4. singleton pregnancy;
  5. living in the local area for one year or more.
Exclusion Criteria
  1. pregnant women with serious chronic diseases and infectious diseases (such as cancer, chronic cardiovascular and cerebrovascular diseases, chronic renal failure, HIV infection);
  2. have participated in other scientific research projects;
  3. refuse to participate or are unwilling to sign informed consent.;
  4. are unable to guarantee delivery in our designated hospitals.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NantongNo intervention-
BeijingNo intervention-
GuangzhouNo intervention-
JinanNo intervention-
NanjingNo intervention-
HangzhouNo intervention-
XiangyangNo intervention-
SuizhouNo intervention-
HuangshiNo intervention-
ZunyiNo intervention-
ChangzhouNo intervention-
ShiyanNo intervention-
XiaoganNo intervention-
SuqianNo intervention-
WuhanNo intervention-
HuanggangNo intervention-
Primary Outcome Measures
NameTimeMethod
Incidence of gestational diabetesDuring pregnancy (up to 10 months)
Incidence of preterm birthDelivery
Incidence of fetal death/stillbirthafter 20 gestational weeks to delivery
Incidence of pregnancy with hyperthyroidismDuring pregnancy (up to 10 months)
Incidence of low birth weightDelivery
Incidence of pregnancy with heart diseaseDuring pregnancy (up to 10 months)
Incidence of birth defectsDelivery
Incidence of gestational hypertensionDuring pregnancy (up to 10 months)
Incidence of spontaneous abortionup to 28 gestational weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (19)

Haidian Maternal and Child Healthcare Hospital

🇨🇳

Beijing, Beijing, China

People's Hospital of Qichun County

🇨🇳

Huanggang, Hubei, China

Xiangyang No. 1 People's Hospital, Hubei University of Medicine

🇨🇳

Xiangyang, Hubei, China

Changzhou Second People's Hospital

🇨🇳

Changzhou, Jiangsu, China

Women's Hospital, School of Medicine, Zhejiang University

🇨🇳

Hanzhou, Zhejiang, China

The First Affiliated Hospital of Zunyi Medical University

🇨🇳

Zunyi, Guizhou, China

Huangshi Maternal and Child Healthcare Hospital

🇨🇳

Huangshi, Hubei, China

Maternal and Child Healthcare and Family Planning Service Center of Zengdu District

🇨🇳

Suizhou, Hubei, China

Anlu Maternal and Child healthcare Hospital

🇨🇳

Xiaogan, Hubei, China

Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

Maternal and Child Healthcare Hospital of HuBei

🇨🇳

Wuhan, Hubei, China

Shiyan Maternal and Child Healthcare Hospital

🇨🇳

Shiyan, Hubei, China

Nantong Maternal and Child Healthcare Hospital

🇨🇳

Nantong, Jiangsu, China

Shuyang Hospital Affiliated to Xuzhou Medical University

🇨🇳

Suqian, Jiangsu, China

Huangpi Maternal and Child Healthcare Hospital

🇨🇳

Wuhan, Hubei, China

Meitan People's Hospital

🇨🇳

Zunyi, Guizhou, China

Renhuai Hospital of Traditional Chinese Medicine

🇨🇳

Zunyi, Guizhou, China

The Second Affliated Hospital of Zunyi Medical University

🇨🇳

Zunyi, Guizhou, China

Center for Reproductive Medicine, Shandong University

🇨🇳

Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath